Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shock.
Beyer
Jan
J
Halbritter
Kai
K
Weise
Matthias
M
Schellong
Sebastian
S
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage; D000991:Antithrombins / Q000008:administration & dosage*; D001120:Arginine / Q000031:analogs & derivatives; D001777:Blood Coagulation / Q000187:drug effects*; D005260:Female; D006801:Humans; D010875:Pipecolic Acids / Q000008:administration & dosage*; D012772:Shock, Septic / Q000150:complications* / Q000188:drug therapy*; D013449:Sulfonamides; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control*
D000925:Anticoagulants; D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D001120:Arginine; C031942:argatroban